Mevalonate prevents lovastatin-induced apoptosis in medulloblastoma cell lines

Canadian Journal of Neurological Sciences

Volumn 26, Issue 4, 1999, Pages 305-310

  Wei, Wang ^a   Macaulay, Robert J B ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVALONIC ACID; MEVINOLIN;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CHOLESTEROL SYNTHESIS; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; NORTHERN BLOTTING; PRIORITY JOURNAL;

EID: 0344562899     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0317167100000433     Document Type: Article

References (41)

1. Boring CC, Squires TS and Tong T. Cancer statistics, 1991 [published erratum appears in CA Cancer J Clin 1991 Mar-Apr;41(2):111].Ca Cancer J Clin 1991; 41: 19-36.
2. Jay V and Becker, LE. Brain tumors. Curr Opin Neurol Neurosurg 1990; 3: 934-942.
3. Schoenberg BS, Schoenberg DG, Christine BW and Gomez MR. The epidemiology of primary intracranial neoplasms of childhood. Mayo Clin Proc 1976; 51: 51-56.
4. Packer RJ. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU and vincristine chemotherapy. J Neurosurg 1994; 81: 690-698.
5. Rorke LB, Trojanowski JQ, Lee VM et al. Primitive neuroectodermal tumors of the central nervous system. Brain Pathol 1997; 7: 765-84.
6. Torres CF, Rebsamen S, Silber JH, et al. Surveillance scanning of children with medulloblastoma. N Engl J Med 1994; 330: 892-5.
7. Tomlinson FH, Scheithauer BW, Meyer FB et al. Medulloblastoma: I. Clinical, diagnostic, and therapeutic overview. J Child Neurol 1992; 7: 142-55.
8. Nishiyama K, Funakoshi S, Izumoto S et al. Long-term effects of radiation for medulloblastoma on intellectual and physical development. A case report of monozygotic twins. Cancer 1994; 73: 2450-5.
9. Tishler DM, Weinberg KI, Sender LS et al. Multidrug resistance gene expression in pediatric primitive neuroectodermal tumors of the central nervous system. J Neurosurg 1992; 76: 507-12.
10. Tobert JA, Hitzenberger G, Kukovetz WR et al. Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme A reductase. Atherosclerosis 1982; 41: 61-5.
11. Poon RY, Toyoshima H and Hunter T. Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol Biol Cell 1995; 6: 1197-213.
12. Goldstein JL and Brown MS. Regulation of the mevalonate pathway. Nature 1990; 343: 425-30.
13. Hancock JF, Magee AI, Childs JE and Marshall CJ. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 1989; 57: 1167-77.
14. O'Donnell MP, Kasiske BL, Kim Y et al. The mevalonate pathway: importance in mesangial cell biology and glomerular disease. Miner Electrolyte Metab 1993; 19: 173-9.
15. Keyomarsi K, Sandoval L, Band V and Pardee AB. Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res 1991; 51: 3602-9.
16. Khosravi FR, Cox AD, Kato K and Der CJ. Protein prenylation: key to ras function and cancer intervention? Cell Growth Differ 1992; 3: 461-9.
17. Law RE, Stimmel JB, Damore MA et al. Lipopolysaccharide-induced NF-kappa B activation in mouse 70Z/3 pre-B lymphocytes is inhibited by mevinolin and 5′-methylthioadenosine: roles of protein isoprenylation and carboxyl methylation reactions. Mol Cell Biol 1992; 12: 103-11.
18. Dimitroulakos J, Pienkowska M, Squire J et al. Differential display of mRNAs using PCR (DD-PCR) to identify genes involved in the growth and differentiation of human neuroblastomas (abstract). Brain Pathol 1994; 4: 427.
19. Newman A, Clutterbuck RD, Powles RL and Millar JL. Selective inhibition of primary acute myeloid leukemia cell growth by lovastatin [corrected and republished in Leukemia 1994 Nov;8(11):2022-9]. Leukemia 1994; 8: 274-80.
20. Dimitroulakos J, Nohynek D, Backway KL et al. Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: a potential therapeutic approach. Blood 1999; 93: 1308-18.
21. Maltese WA, Defendini R, Green RA et al. Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Clin Invest 1985; 76: 1748-54.
22. Macaulay RJB, Wang W, Dimitroulakos J et al. Lovastatin-induced apoptosis of human medulloblastoma cell lines in vitro. J Neuro-Oncol 1999; 42: 1-11.
23. Bansal N, Houle AG and Melnykovych G. Comparison of dexamethasone and lovastatin (mevinolin) as growth inhibitors in cultures of T-cell derived human acute leukemia lines (CEM). Leuk Res 1989; 13: 875-82.
24. Perez SD and Mollinedo F. Inhibition of isoprenoid biosynthesis induces apoptosis in human promyelocytic HL-60 cells. Biochem Biophys Res Commun 1994; 199: 1209-15.
25. Jones KD, Couldwell WT, Hinton DR et al. Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells. Biochem Biophys Res Commun 1994; 205: 1681-7.
26. Keles GE, Berger MS, Srinivasan J et al. Establishment and characterization of four human medulloblastoma-derived cell lines. Oncol Res 1995; 7: 493-503.
27. Ramharack R, Tam SP and Deeley RG. Characterization of three distinct size classes of human 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA: expression of the transcripts in hepatic and nonhepatic cells. DNA Cell Biol 1990; 9: 677-90.
28. Ercolani L, Florence B, Denaro M and Alexander M. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem 1988; 263: 15335-41.
29. Wong H, Anderson WD, Cheng T and Riabowol KT. Monitoring mRNA expression by polymerase chain reaction: the "primer-dropping" method. Anal Biochem 1994; 223: 251-8.
30. Dimitroulakos J and Yeger H. HMG-CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: lovastatin specifically targets P-glycoprotein-expressing cells. Nat Med 1996; 2: 326-33.
31. Finegold AA, Schafer WR, Rine J et al. Common modifications of trimeric G proteins and ras protein: involvement of polyisoprenylation. Science 1990; 249: 165-9.
32. Wang W and Macaulay RJB. Apoptosis of medulloblastoma cells in vitro follows inhibition of farnesylation using manumycin A. Int J Cancer 1999; 82: 430-434.
33. Pietsch T, Scharmann T, Fonatsch C et al. Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system. Cancer Res 1994; 54: 3278-87.
34. Green DR, Mahboubi A, Nishioka W et al. Promotion and inhibition of activation-induced apoptosis in T-cell hybridomas by oncogenes and related signals. Immunol Rev 1994; 142: 321-42.
35. Askew DS, Ashmun RA, Simmons BC and Cleveland JL. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 1991; 6: 1915-22.
36. Evan GI, Wyllie AH, Gilbert CS et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 119-28.
37. Hermeking H and Eick D. Mediation of c-Myc-induced apoptosis by p53. Science 1994; 265: 2091-3.
38. Duffy MJ. Cellular oncogenes and suppressor genes as prognostic markers in cancer. Clin Biochem 1993; 26: 439-47.
39. Munday NA, Vaillancourt JP, Ali A et al. Molecular cloning and proapoptotic activity of ICEre1II and ICEre1III, members of the ICE/CED-3 family of cysteine proteases. J Biol Chem 1995; 270: 15870-6.
40. Nicholson DW, Ali A, Thornberry NA et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 37-43.
41. Sleath PR, Hendrickson RC, Kronheim SR et al. Substrate specificity of the protease that processes human interleukin-1 beta. J Biol Chem 1990; 265: 14526-8.